Published in Eur J Clin Microbiol Infect Dis on June 17, 2010
Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group. Infect Agent Cancer (2013) 0.81
Current spectrum of bacterial infections in patients with nosocomial fever and neutropenia. Caspian J Intern Med (2013) 0.81
Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia. Genes Immun (2014) 0.80
Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia. J Cancer Res Clin Oncol (2015) 0.78
Evaluation of Bloodstream Infections During Chemotherapy-Induced Febrile Neutropenia in Patients with Malignant Hematological Diseases: Single Center Experience. Eur J Microbiol Immunol (Bp) (2015) 0.75
Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies. South Asian J Cancer (2013) 0.75
Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis (1999) 10.30
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med (1966) 7.30
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med (2005) 5.54
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med (2005) 4.96
Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med (1993) 4.12
Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med (1971) 3.82
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53
Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis (1994) 2.61
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14
Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis (1999) 1.66
Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents (2007) 1.57
Prophylactic antimicrobial agents and the importance of fitness. N Engl J Med (2005) 1.55
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother (1995) 1.31
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother (2008) 1.26
Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection (2001) 1.09
Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis. Infection (1990) 1.06
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. Clin Infect Dis (2006) 1.04
Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis (2007) 1.01
Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. Eur J Clin Microbiol Infect Dis (2006) 1.00
Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis (2003) 1.00
Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer (2004) 0.95
Microbiological findings in febrile neutropenia. Arch Med Res (2000) 0.94
Rational selection of patients for antibacterial prophylaxis after chemotherapy. J Clin Oncol (2007) 0.92
Intestinal permeability in patients with acute myeloid leukemia. Eur J Haematol (1998) 0.90
Antibiotic prophylaxis for patients with acute leukemia. Leuk Lymphoma (2008) 0.83
Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center. Eur J Clin Microbiol Infect Dis (2003) 0.83
Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever. Antimicrob Agents Chemother (2000) 0.80
Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group. Eur J Haematol (2007) 0.79
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial. Bone Marrow Transplant (2006) 0.78
Continuous-monitoring blood culture screening system improves the detection of bacteremia in neutropenic patients. Scand J Infect Dis (1996) 0.75
Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemia. Scand J Infect Dis (2008) 0.75
Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med (1990) 3.21
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33
Spontaneous remission in acute myeloid leukaemia. Br J Haematol (1994) 2.30
Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia (2007) 2.11
Improved outcome after trauma care in university-level intensive care units. Acta Anaesthesiol Scand (2009) 2.09
Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis (1997) 2.08
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99
Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise. Int J Sports Med (1986) 1.91
Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses. Acta Psychiatr Scand (2000) 1.56
Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study. Eur J Haematol (2002) 1.55
Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med (1996) 1.50
Acute myeloblastic leukaemia cells produce soluble interleukin 6 receptor by a mechanism of alternative splicing. Cytokine (1998) 1.46
Recurrent Sphingomonas paucimobilis -bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. J Hosp Infect (2002) 1.44
The hypothalamus-pituitary-gonad axis and testicular function in male patients after treatment for haematological malignancies. J Intern Med (1998) 1.43
Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol (1980) 1.38
Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol (1978) 1.29
Sotalol and prolonged Q-Tc interval. Lancet (1981) 1.27
Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin Cancer Res (2001) 1.20
Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene (1994) 1.19
Five-year outcome of laparoscopic and Lichtenstein hernioplasties. Surg Endosc (2004) 1.17
Epidemiology and seasonal variation of distal radius fractures in Oulu, Finland. Osteoporos Int (2010) 1.14
A cluster of seven cases of Clostridium tertium septicemia in neutropenic patients. Eur J Clin Microbiol Infect Dis (1990) 1.12
Effect of tricyclic antidepressants and alcohol in psychomotor skills related to driving. Clin Pharmacol Ther (1975) 1.10
The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med (1995) 1.10
Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant (2004) 1.09
Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. Cancer Res (2000) 1.07
Statistical inversion for medical x-ray tomography with few radiographs: I. General theory. Phys Med Biol (2003) 1.07
Using additive noise in back-propagation training. IEEE Trans Neural Netw (1992) 1.06
Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study. Arch Pediatr Adolesc Med (1994) 1.06
Sotalol intoxication with prolonged Q-T interval and severe tachyarrhythmias. Br Med J (1979) 1.05
Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma. Int J Cancer (2001) 1.04
Robotic-assisted and laparoscopic ventral rectopexy in the treatment of rectal prolapse: a matched-pairs study of operative details and complications. Tech Coloproctol (2013) 1.04
Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis (1999) 1.02
Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma. Eur J Haematol (1999) 1.02
In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax (2002) 1.02
Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer (2002) 1.00
Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis. Pediatr Pulmonol (1997) 1.00
Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT. Bone Marrow Transplant (2009) 0.99
Asthma, allergic rhinitis and atopic eczema in Finnish children and adolescents. Allergy (1991) 0.99
Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients. Bone Marrow Transplant (2010) 0.98
Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients. Eur J Cancer (1998) 0.98
Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer (1998) 0.98
Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene (1999) 0.98
Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis. Rheumatology (Oxford) (2000) 0.97
Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplant (2004) 0.97
Comparison of remifentanil and nitrous oxide in labour analgesia. Acta Anaesthesiol Scand (2005) 0.97
Central nervous system involvement in patients with mantle cell lymphoma. Ann Hematol (1999) 0.97
An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis (1987) 0.96
Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol (2000) 0.96
Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication. Eur J Clin Pharmacol (1981) 0.96
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries. Bone Marrow Transplant (2011) 0.95
Development of renal failure during the initial 24 h of intensive care unit stay correlates with hospital mortality in trauma patients. Acta Anaesthesiol Scand (2006) 0.95
Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax (2006) 0.95
Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol (2002) 0.95
Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab (2000) 0.95
Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies. J Rheumatol (1996) 0.94
Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003. Eur J Haematol (2006) 0.94
Cardiovascular effects of amitriptyline, nortriptyline, protriptyline and doxepin in conscious rabbits. Eur J Pharmacol (1974) 0.94
Diffractive optical element based sensor for surface quality inspection of concave punches. Eur J Pharm Biopharm (2000) 0.93
Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice. Med Biol (1975) 0.93
Survivorship of high tibial osteotomy in the treatment of osteoarthritis of the knee: Finnish registry-based study of 3195 knees. J Bone Joint Surg Br (2012) 0.93
Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature. Br J Haematol (1989) 0.93
Optical inspection of punches: flat surfaces. Eur J Pharm Biopharm (2000) 0.93
Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. J Intern Med (2002) 0.92
Prevalence of asthma at school age: a clinical population-based study in eastern Finland. Acta Paediatr (1996) 0.92
Oral activated charcoal and dapsone elimination. Clin Pharmacol Ther (1980) 0.92
Hospital water supply as a source of disseminated Mycobacterium fortuitum infection in a leukemia patient. Infect Control Hosp Epidemiol (1999) 0.92
Epidemiology of Achilles tendon ruptures: increasing incidence over a 33-year period. Scand J Med Sci Sports (2014) 0.91
Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand (2003) 0.91
Circadian rhythm of white blood cells during clozapine treatment. Psychopharmacology (Berl) (1999) 0.90
Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. Pharmacology (1993) 0.90
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (2001) 0.90
Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax (2004) 0.90
Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol (2006) 0.90
Epidemiology of intensive care unit (ICU)-acquired infections in a 14-month prospective cohort study in a single mixed Scandinavian university hospital ICU. Acta Anaesthesiol Scand (2006) 0.89
Microscopic transmission ellipsometry: measurement of the fibril angle and the relative phase retardation of single, intact wood pulp fibers. Appl Opt (1994) 0.89
BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy. Leuk Lymphoma (2003) 0.89
Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol (2004) 0.89
High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol. Bone Marrow Transplant (2006) 0.89
Bronchial asthma after early childhood wheezing: a follow-up until 4.5-6 years of age. Acta Paediatr (1994) 0.89
MicroRNA profiling in chemoresistant and chemosensitive acute myeloid leukemia. Cytogenet Genome Res (2013) 0.88
Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocytic leukaemia. Eur J Haematol (1996) 0.88
Infections and serum IgG levels in patients with chronic lymphocytic leukemia. Eur J Haematol (1992) 0.87
Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress. Ann Oncol (1999) 0.87
Evaluation of an antigen-capture enzyme immunoassay for rapid diagnosis of Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis (1993) 0.87